October 31, 2023 11:28 AM EDT
Manufacturing

As In­dia grows its bi­o­log­ics mar­ket, Ara­gen builds new $30M fa­cil­i­ty

Anna Brown

News Reporter

Ara­gen Life Sci­ences is launch­ing a new $30 mil­lion bi­o­log­ics man­u­fac­tur­ing site in Ban­ga­lore due to grow­ing de­mand, the In­dia-based drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times